BR100 Increased By (0.93%)
BR30 Increased By (1.42%)
KSE100 Increased By (0.53%)
KSE30 Increased By (0.58%)
BECO 6.09 Increased By ▲ 0.32 (5.55%)
BML 53.40 Increased By ▲ 0.40 (0.75%)
BOP 34.30 Increased By ▲ 0.31 (0.91%)
CNERGY 8.18 Increased By ▲ 0.07 (0.86%)
DCL 12.15 Decreased By ▼ -0.05 (-0.41%)
FCCL 53.80 Increased By ▲ 0.97 (1.84%)
FCSC 5.19 Increased By ▲ 0.12 (2.37%)
FFL 18.10 Increased By ▲ 0.15 (0.84%)
FNEL 1.30 Increased By ▲ 0.01 (0.78%)
HUMNL 10.91 Increased By ▲ 0.03 (0.28%)
KEL 8.14 Increased By ▲ 0.12 (1.5%)
KOSM 5.36 Decreased By ▼ -0.16 (-2.9%)
MLCF 87.79 Increased By ▲ 1.28 (1.48%)
NBP 187.20 Increased By ▲ 2.04 (1.1%)
PACE 10.72 Increased By ▲ 0.14 (1.32%)
PAEL 39.75 Increased By ▲ 0.33 (0.84%)
PIAHCLA 26.18 Decreased By ▼ -0.04 (-0.15%)
PIBTL 17.41 Increased By ▲ 0.74 (4.44%)
PPL 231.50 Increased By ▲ 3.32 (1.45%)
PRL 35.01 Increased By ▲ 0.33 (0.95%)
PTC 67.60 Increased By ▲ 2.27 (3.47%)
SEARL 90.90 Increased By ▲ 0.77 (0.85%)
SSGC 27.10 Increased By ▲ 0.50 (1.88%)
TELE 8.66 Increased By ▲ 0.38 (4.59%)
THCCL 58.25 Decreased By ▼ -0.25 (-0.43%)
TPLP 8.85 Increased By ▲ 0.63 (7.66%)
TREET 24.56 Increased By ▲ 0.03 (0.12%)
TRG 71.40 Increased By ▲ 1.69 (2.42%)
WAVES 10.00 Increased By ▲ 0.06 (0.6%)
WTL 1.28 No Change ▼ 0.00 (0%)
اردو
Android App
Print Edition Dollar to PKR
Budget 2026-27 Iran-US war Petrol Prices Gold Rates Podcasts PSX Notices
Topic

Pfizer vaccine doses

J&J raises forecasts, estimates $2.5bn in COVID-19 vaccine sales

J&J raises forecasts, estimates $2.5bn in COVID-19 vaccine sales

Published 21 Jul, 2021 05:53pm
  • Pfizer and Moderna forecast $26 billion and $19.2 billion in annual sales of their vaccines, respectively
  • J&J raised its expectations for full-year sales to a range of $93.8 billion to $94.6 billion including contribution from the single-dose vaccine, and to $91.3 billion-$92.1 billion for the rest of the business
Countries vaccinating children against Covid-19 all over the world

Countries vaccinating children against Covid-19 all over the world

Published 16 Jun, 2021 07:12pm
  • Pfizer is now planning to test its vaccine on children aged between five to 11, while China has approved Sinovac Biotech's shot for emergency use in children as young as three
  • Italy on May 31 approved extending the use of Pfizer's vaccine to 12-15 year olds.
EU regulator backs Pfizer-BioNTech COVID-19 vaccine for adolescents

EU regulator backs Pfizer-BioNTech COVID-19 vaccine for adolescents

Published 28 May, 2021 08:23pm
  • The European Medicines Agency's endorsement comes weeks after it began evaluating extending use of the vaccine, developed with Germany's BioNTech, to include 12- to 15-year-olds. It is already being used in the European Union for those aged 16 and older.
  • Inoculating children and young people is considered a critical step toward reaching "herd immunity" and taming the pandemic.
Moderna to deliver 25 million COVID-19 vaccine doses to Australia

Moderna to deliver 25 million COVID-19 vaccine doses to Australia

Published 12 May, 2021 05:16pm
  • It has been trying to speed up the rollout of jabs after it was stalled by supply hold-ups in Europe and concerns about blood clots tied to the AstraZeneca shot.
  • The deal also includes the supply of 15 million doses of Moderna's updated variant booster vaccine candidate to be delivered in 2022, the company said.
Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU

Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU

Published 30 Apr, 2021 04:51pm
  • The companies filed a similar request in the United States earlier this month for the vaccine, which is already authorized for use in people from 16 years of age in both the United States and the European Union.
  • The submissions are based on positive data from a late-stage clinical trial that enrolled 2,260 participants aged 12 to 15, the companies said.
South Korea signs with Pfizer for additional 40mn COVID-19 vaccine doses

South Korea signs with Pfizer for additional 40mn COVID-19 vaccine doses

Published 24 Apr, 2021 05:58pm
  • It added that it had secured a total 192 million doses of vaccines, including those from Moderna Inc, AstraZeneca PLC, Johnson & Johnson's and Novavax.
  • "The government has acquired COVID-19 vaccines large enough to vaccinate approximately 100 million people...(which) is double the entire population of South Korea," Health Minister Kwon Deok-cheol told a briefing.
UK doctors call for shorter gap between Pfizer vaccine doses

UK doctors call for shorter gap between Pfizer vaccine doses

Published 23 Jan, 2021 06:22pm
Britain is prioritising giving first doses of COVID-19 vaccine, allowing up to 12 weeks before a second dose, to give the maximum number of people some initial protection. * It therefore urged the CMO to "urgently review the UK's current position of second doses after 12 weeks".
Loading...